Judgment of the General Court (Fourth Chamber) of 27 February 2018 –Hansen Medical v EUIPO – Covidien (MAGELLAN)
(Case T-222/16)
(EU trade mark — Revocation proceedings — EU word mark MAGELLAN — Genuine use — Burden of proof — Article 15 and Article 51(1)(a) of Regulation (EC) No 207/2009 (now Article 18 and Article 58(1)(a) of Regulation (EU) 2017/1001) — Procedural irregularity committed by the Cancellation Division — Obligation to state reasons — Article 75 of Regulation No 207/2009 (now Article 94 of Regulation 2017/1001) — Oral proceedings — Article 77 of Regulation No 207/2009 (now Article 96 of Regulation 2017/1001))
1.      EU trade mark – Surrender, revocation and invalidity – Causes of revocation – Absence of genuine use of a trade mark – Proof of use of the earlier mark – Partial use – Effect – Concept of (part of the goods or services) covered by the registration
(Council Regulation No 207/2009, Arts 15 and 51(1)(a))
(see paras 25-28)
2.      EU trade mark – Appeals procedure – Appeal brought against a decision by a department of EUIPO – Examination by the Board of Appeal – Scope
(Council Regulation No 207/2009, Art. 64(1))
(see para. 44)
3.      EU trade mark – Procedural provisions – Statement of reasons for decisions – First sentence of Article 75 of Regulation No 207/2009 – Scope identical to that of Article 296 TFEU
(Art. 296 TFEU; Council Regulation No 207/2009, Art. 75, first sentence)
(see paras 49, 50)
4.      EU trade mark – Procedural provisions – Recourse to the oral procedure – Discretion of the Office
(Council Regulation No 207/2009, Art. 77(1))
(see para. 58)
Re:
Action brought against the decision of the Second Board of Appeal of EUIPO of 3 February 2016 (Cases R 3092/2014-2 and R 3118/2014-2), relating to revocation proceedings between Hansen Medical and Covidien.
Operative part
The Court:
1.
Dismisses the action;
2.
Orders Hansen Medical, Inc. to pay the costs.
2.
Orders Hansen Medical, Inc. to pay the costs.